JEAKEN LTD

Company Registration Number:
11035582 (England and Wales)

Unaudited micro entity accounts for the year ended 31 October 2024

Period of accounts

Start date: 01 November 2023

End date: 31 October 2024

JEAKEN LTD

Contents of the Financial Statements

for the Period Ended 31 October 2024

Company Information - 3
Report of the Directors - 4
Profit and Loss Account - 5
Balance sheet - 6
Footnotes to the Balance Sheet - 8

JEAKEN LTD

Company Information

for the Period Ended 31 October 2024




Director: Alexis Kenne
Registered office: 7 Bell Yard
7 Bell Yard
London
England
WC2A 2JR
Company Registration Number: 11035582 (England and Wales)

JEAKEN LTD

Directors' Report Period Ended 31 October 2024

The directors present their report with the financial statements of the company for the period ended 31 October 2024

Principal Activities

The principal activity of the company during the year continued to be the sale and distribution of health and wellness products.

Political and charitable donations

The company made no political donations and no charitable donations during the year ended 31 October 2024.

Company policy on the employment of disabled persons

JeaKen Ltd is committed to providing equal opportunities in employment and to avoiding unlawful discrimination. Applications for employment by disabled persons are fully considered based on individual aptitudes and abilities. If an employee becomes disabled, efforts are made to retain them and provide necessary training. The company ensures that training, development, and promotions are available to all employees.

Additional information

The company continues to invest in stock for future growth. Management is reviewing cost efficiency strategies to return the company to profitability.

Directors

The directors shown below have held office during the whole of the period from 01 November 2023 to 31 October 2024
Alexis Kenne

This report was approved by the board of directors on 21 July 2025
And Signed On Behalf Of The Board By:

Name: Alexis Kenne
Status: Director

JEAKEN LTD

Profit and Loss Account

for the Period Ended 31 October 2024


2024
£

2023
£
Turnover 95,650 152,297
Income from coronavirus (COVID-19) business support grants 0 0
Other Income 50,000 0
Cost of Materials ( 127,998 ) ( 145,661 )
Staff Costs ( 8,265 ) ( 8,265 )
Depreciation and Writeoffs ( 0 ) ( 0 )
Other charges ( 20,869 ) -
Tax on Profit ( 0 ) ( 0 )
Profit or (Loss) for Period ( 11,482 ) ( 1,629 )

JEAKEN LTD

Balance sheet

As at 31 October 2024


2024
£

2023
£
Called up share capital not paid: 0 0
Fixed Assets: 0 0
Current assets: 1,500 0
Prepayments and accrued income: 5,000 0
Creditors: amounts falling due within one year: ( 0 ) ( 1,636 )
Net current assets (liabilities): 6,500 ( 1,636 )
Total assets less current liabilities: 6,500 ( 1,636 )
Creditors: amounts falling due after more than one year: ( 85,000 ) ( 35,000 )
Provision for liabilities: ( 0 ) ( 0 )
Accruals and deferred income: ( 0 ) ( 0 )
Total net assets (liabilities): ( 78,500 ) ( 36,636 )
Capital and reserves: ( 78,500 ) ( 36,636 )

JEAKEN LTD

Balance sheet continued

For the year ending 31 October 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions of the small companies regime applicable to micro-entities.

This report was approved by the board of directors on 21 July 2025
And Signed On Behalf Of The Board By:

Name: Alexis Kenne
Status: Director

The notes form part of these financial statements

JEAKEN LTD

Footnotes to the Financial Statements

for the Period Ended 31 October 2024

  • 1. Employee Information

    Average number of employees: 1

JEAKEN LTD

Footnotes to the Financial Statements

for the Period Ended 31 October 2024

  • 2. Off balance sheet disclosure

    No